Completed OBSERVATIONAL NCT04533867

Palonosetron vs. Ondansetron for Postoperative Nausea and Vomiting in Bariatric Surgery

Comparison of Palonosetron and Ondansetron for the Prevention of Postoperative Nausea and Vomiting After Bariatric Surgery

Sponsor: Bagcilar Training and Research Hospital

Conditions Antiemetics Nausea, Postoperative Pain, Postoperative Patient Reported Outcomes Vomiting, Postoperative

Interventions Laparoscopic sleeve gastrectomy Ondansetron 1 mg/kg, max dose 8 mg Palonosetron 1mcg/kg

Updated 6 times since 2020 Last updated: Jan 21, 2021 Started: Aug 15, 2020 Primary completion: Dec 15, 2020 Completion: Jan 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Antiemetics and Nausea, Postoperative and is currently completed. Bagcilar Training and Research Hospital leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2021 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting

▶ Show 1 earlier version

Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting

First recorded

Aug 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bagcilar Training and Research Hospital

Data source: Bagcilar Training and Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Istanbul, Turkey (Türkiye)